LifeMap Sciences, a Subsidiary of BioTime, Announces Release of...
LifeMap Sciences, Inc., a subsidiary of BioTime, Inc., announced today the release of GeneCards Version 3.12.
BioTime Director Broadwood Partners Lp Buys 1,000,000 Shares
BioTime Director Broadwood Partners Lp bought 1,000,000 shares of the company's stock in a transaction dated Monday, June 16th.
BioTime Subsidiary Asterias Biotherapeutics Announces Investment By CEO
ALAMEDA, Calif. & MENLO PARK, Calif.-- --BioTime, Inc. today announced that on June 12, 2014, Pedro Lichtinger, President and Chief Executive Officer of its subsidiary Asterias Biotherapeutics, Inc. purchased from Asterias 200,000 shares of Asterias Series B common stock at a price of $2.34 per share.
Contract Pharma Breaking News
BioTime Names CEO of Asterias Biotherapeutics
Pedro Lichtinger has been appointed president and chief executive officer of BioTime's subsidiary Asterias Biotherapeutics , which was created for the acquisition of Geron Corp.'s clinical-stage stem cell therapeutic assets.
Asterias Biotherapeutics Brings In Ex-Pfizer Inc. Senior Executive As President And CEO
BioTime Subsidiary Asterias Biotherapeutics Appoints Former Pfizer Senior Executive Pedro Lichtinger as President and Chief Executive Officer * Pharmaceutical and Biotechnology Industry Professional with 35 Years of Experience * Extensive Track Record of Successful Drug Development and Commercialization * Focused on Advancing Lead Product ... (more)